Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.7.1
Dataset results
388 results for “alcoholic fatty liver disease”
Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT05506488. IPD Sharing: NO. Countries: 1. Publications: 0.
Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT02884037. IPD Sharing: NO. Countries: 1. Publications: 0.
Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06942312. IPD Sharing: NO. Countries: 1. Publications: 0.
Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced Fibrosis
ClinicalTrials.gov study NCT05050721. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT01511523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
ClinicalTrials.gov study NCT06493799. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents
ClinicalTrials.gov study NCT02216552. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03437720. IPD Sharing: YES. Countries: 0. Publications: 0.
Association Between Non-alcoholic Fatty Liver Disease and Iron Status
ClinicalTrials.gov study NCT01307254. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01876108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
ClinicalTrials.gov study NCT05843955. IPD Sharing: NO. Countries: 1. Publications: 0.
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
ClinicalTrials.gov study NCT01997424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01894438. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT01167088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
ClinicalTrials.gov study NCT03910361. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis
ClinicalTrials.gov study NCT02068339. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to
ClinicalTrials.gov study NCT06403332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone
ClinicalTrials.gov study NCT02875821. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis
ClinicalTrials.gov study NCT04142749. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Association Between Non-alcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Calcification
ClinicalTrials.gov study NCT01158066. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.